Background: Speed congenics is an important tool for creating congenic mice to investigate gene functions, but current SNP genotyping methods for speed congenics are expensive. These methods usually rely on chip or array technologies, and a different assay must be developed for each backcross strain combination. “Next generation” high throughput DNA sequencing technologies have the potential to decrease cost and increase flexibility and power of speed congenics, but thus far have not been utilized for this purpose. Results: We took advantage of the power of high throughput sequencing technologies to develop a cost-effective, high-density SNP genotyping assay that can be used across many combinations of backcross strains. The assay surveys 1640 genome-wide SNPs known to be polymorphic across > 100 mouse strains, with an expected average of 549 ± 136 SD diagnostic SNPs between each pair of strains. We demonstrated that the assay has a high density of diagnostic SNPs for backcrossing the BALB/c strain into the C57BL/6J strain (807–819 SNPs), and a sufficient density of diagnostic SNPs for backcrossing the closely related substrains C57BL/6N and C57BL/6J (123–139 SNPs). Furthermore, the assay can easily be modified to include additional diagnostic SNPs for backcrossing other closely related substrains. We also developed a bioinformatic pipeline for SNP genotyping and calculating the percentage of alleles that match the backcross recipient strain for each sample; this information can be used to guide the selection of individuals for the next backcross, and to assess whether individuals have become congenic. We demonstrated the effectiveness of the assay and bioinformatic pipeline with a backcross experiment of BALB/c-IL4/IL13 into C57BL/6J; after six generations of backcrosses, offspring were up to 99.8% congenic. Conclusions: The SNP genotyping assay and bioinformatic pipeline developed here present a valuable tool for increasing the power and decreasing the cost of many studies that depend on speed congenics. The assay is highly flexible and can be used for combinations of strains that are commonly used for speed congenics. The assay could also be used for other techniques including QTL mapping, standard F2 crosses, ancestry analysis, and forensics.
Malaria is strongly predisposed to bacteremia, which is associated with increased gastrointestinal permeability and a poor clinical prognosis. We previously identified mast cells (MCs) as mediators of intestinal permeability in malaria and described multiple cytokines that rise with parasitemia, including interleukin (IL)-10, which could protect the host from an inflammatory response and alter parasite transmission to Anopheles mosquitoes. Here, we used the Cre-loxP system and non-lethal Plasmodium yoelii yoelii 17XNL to study the roles of MC-derived IL-10 in malaria immunity and transmission. Our data suggest a sex-biased and local inflammatory response mediated by MC-derived IL-10, supported by early increased number and activation of MCs in females relative to males. Increased parasitemia in female MC IL-10 (−) mice was associated with increased ileal levels of chemokines and plasma myeloperoxidase (MPO). We also observed increased intestinal permeability in female and male MC IL-10 (−) mice relative to MC IL-10 (+) mice but no differences in blood bacterial 16S DNA levels. Transmission success of P. yoelii to A. stephensi was higher in female relative to male mice and from female and male MC IL-10 (−) mice relative to MC IL-10 (+) mice. These patterns were associated with increased plasma levels of pro-inflammatory cytokines in female MC IL-10 (−) mice and increased plasma levels of chemokines and markers of neutrophil activation in male MC IL-10 (−) mice. Overall, these data suggest that MC-derived IL-10 protects intestinal barrier integrity, regulates parasite transmission, and controls local and systemic host immune responses during malaria, with a female bias.
Malaria predisposes individuals to concurrent bacteremia, a complication associated with increased intestinal permeability and mast cell (MC) activation. These effects correlate with elevated type-2 cytokines, including interleukin (IL)-3, IL-4, and IL-10. We previously demonstrated that basophils regulate MC activation and protect intestinal barrier integrity during malaria. Because FcεR1γ signaling is required for basophil IL-4 production, we monitored parasitemia, barrier integrity, bacteremia, and cytokine and chemokine profiles in male and female mice with basophil-specific deletion of FcεR1γ [baso Fcer1g (−)], generated by crossing Mcpt8 -Cre and Fcer1gflox/flox mice. Baso Fcer1g (−) mice retain IL-3 responsiveness but fail to produce IL-4 upon activation. Mice were infected with Plasmodium yoelii 17XNL to assess the role of basophil FcεR1γ signaling during infection. Basophil FcεR1γ deficiency had no effect on parasitemia. However, female baso Fcer1g (−) mice exhibited significantly increased intestinal permeability by day 6 post-infection (PI) compared to genotype controls. Despite this enhanced barrier disruption, bacterial 16S levels in blood were reduced in female baso Fcer1g (−) mice by day 10 PI relative to female controls and mutant males. Increased permeability was associated with elevated ileal IL-6 and CCL4, and increased plasma CCL3 and CCL5 at day 6 PI. At day 10 PI, reduced bacteremia correlated with increased systemic IL-17A and GM-CSF, and reduced IL-10 and Mcpt1, indicating reduced MC activation. These findings demonstrate that basophil FcεR1γ signaling shapes female-biased mucosal and systemic immune responses during malaria, extending our understanding of sex-specific gut-systemic immune crosstalk during infection.